MOUNTAIN VIEW, Calif.,
April 1, 2015 /PRNewswire/ --
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and
supply management solutions for healthcare institutions, today
announced it had received notification from the Nasdaq Stock Market
that the Company is now in compliance with Nasdaq Listing Rule
5250(c)(1), based on the March 30, 2015 filing of Omnicell's Form
10-K for the period ended December 31, 2014. Nasdaq indicated the
matter is now closed.
On March 18, 2015, the Company
received notice from Nasdaq that the Company was not in compliance
with the listing rule, due to the delay in filing its Annual Report
on Form 10-K, beyond the extended filing due date of March 17, 2015. Omnicell filed its Form 10-K on
March 30, 2015 to conclude the
matter.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new
efficiencies to improve patient care, anywhere it is delivered.
Omnicell is a leading supplier of comprehensive automation and
business analytics software for patient-centric medication and
supply management across the entire healthcare continuum
- from the acute care hospital setting to post-acute skilled
nursing and long-term care facilities to the home.
More than 3,000 customers worldwide have utilized Omnicell
Automation and Analytics solutions to increase operational
efficiency, reduce errors, deliver actionable intelligence and
improve patient safety. Omnicell Medication Adherence solutions,
including its MTS Medication Technologies brand, provide innovative
medication adherence packaging solutions to help reduce costly
hospital readmissions. In addition, these solutions enable
approximately 6,000 institutional and retail pharmacies worldwide
to maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
For more information about Omnicell, Inc. please visit
www.omnicell.com.
OMCL-E
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-regains-nasdaq-listing-compliance-300059182.html
SOURCE Omnicell, Inc.